Dataset Information

Alterations of Graphic Properties and Related Cognitive Functioning Changes in Mild Alzheimer's Disease Revealed by Individual Morphological Brain Network.

ABSTRACT: Alzheimer's disease (AD) is one of the most common forms of dementia that has slowly negative impacts on memory and cognition. With the assistance of multimodal brain networks and graph-based analysis approaches, AD-related network disruptions support the hypothesis that AD can be identified as a dysconnectivity syndrome. However, as the recent emerging of individual-based morphological network research of AD, the utilization of multiple morphometric features may provide a broader horizon for locating the lesions. Therefore, the present study applied the newly proposed individual morphological brain network with five commonly used morphometric features (cortical thickness, regional volume, surface area, mean curvature, and fold index) to explore the topological aberrations and their relationship with cognitive functioning alterations in the early stage of AD. A total of 40 right-handed participants were selected from Open Access Series of Imaging Studies Database with 20 AD patients (age ranged from 70 to 79, CDR = 0.5) and 20 age/gender-matched healthy controls. The significantly affected connections (p < 0.05 with FDR correction) were observed across multiple regions, both enhanced and attenuated correlations, primarily related to the left entorhinal cortex (ENT). In addition, profoundly changed Mini Mental State Examination (MMSE) score and global efficiency (p < 0.05) were noted in the AD patients, as well as the pronounced inter-group distinctions of betweenness centrality, global and local efficiency (p < 0.05) in the higher MMSE score zone (28-30), which indicating the potential role of graphic properties in determination of early-stage AD patients. Moreover, the reservations (regions in the occipital and frontal lobes) and alterations (regions in the right temporal lobe and cingulate cortex) of hubs were also detected in the AD patients. Overall, the findings further confirm the selective AD-related disruptions in morphological brain networks and also suggest the feasibility of applying the morphological graphic properties in the discrimination of early-stage AD patients.

SUBMITTER: Li W

PROVIDER: S-EPMC6295573 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Alterations of Graphic Properties and Related Cognitive Functioning Changes in Mild Alzheimer's Disease Revealed by Individual Morphological Brain Network.

Li Wan W Yang Chunlan C Wu Shuicai S Nie Yingnan Y Zhang Xin X Lu Ming M Chu Tongpeng T Shi Feng F

Frontiers in neuroscience 20181210

Alzheimer's disease (AD) is one of the most common forms of dementia that has slowly negative impacts on memory and cognition. With the assistance of multimodal brain networks and graph-based analysis approaches, AD-related network disruptions support the hypothesis that AD can be identified as a dysconnectivity syndrome. However, as the recent emerging of individual-based morphological network research of AD, the utilization of multiple morphometric features may provide a broader horizon for lo ...[more]

PMID: 30618556

Similar Datasets

Project description:ImportanceBiomarkers do not determine conversion to Alzheimer disease (AD) perfectly, and criteria do not specify how to take patient characteristics into account. Consequently, biomarker use may be challenging for clinicians, especially in patients with mild cognitive impairment (MCI).ObjectiveTo construct biomarker-based prognostic models that enable determination of future AD dementia in patients with MCI.Design, setting, and participantsThis study is part of the Alzheimer's Biomarkers in Daily Practice (ABIDE) project. A total of 525 patients with MCI from the Amsterdam Dementia Cohort (longitudinal cohort, tertiary referral center) were studied. All patients had their baseline visit to a memory clinic from September 1, 1997, through August 31, 2014. Prognostic models were constructed by Cox proportional hazards regression with patient characteristics (age, sex, and Mini-Mental State Examination [MMSE] score), magnetic resonance imaging (MRI) biomarkers (hippocampal volume, normalized whole-brain volume), cerebrospinal fluid (CSF) biomarkers (amyloid-β1-42, tau), and combined biomarkers. Data were analyzed from November 1, 2015, to October 1, 2016.Main outcomes and measuresClinical end points were AD dementia and any type of dementia after 1 and 3 years.ResultsOf the 525 patients, 210 (40.0%) were female, and the mean (SD) age was 67.3 (8.4) years. On the basis of age, sex, and MMSE score only, the 3-year progression risk to AD dementia ranged from 26% (95% CI, 19%-34%) in younger men with MMSE scores of 29 to 76% (95% CI, 65%-84%) in older women with MMSE scores of 24 (1-year risk: 6% [95% CI, 4%-9%] to 24% [95% CI, 18%-32%]). Three- and 1-year progression risks were 86% (95% CI, 71%-95%) and 27% (95% CI, 17%-41%) when MRI results were abnormal, 82% (95% CI, 73%-89%) and 26% (95% CI, 20%-33%) when CSF test results were abnormal, and 89% (95% CI, 79%-95%) and 26% (95% CI, 18%-36%) when the results of both tests were abnormal. Conversely, 3- and 1-year progression risks were 18% (95% CI, 13%-27%) and 3% (95% CI, 2%-5%) after normal MRI results, 6% (95% CI, 3%-9%) and 1% (95% CI, 0.5%-2%) after normal CSF test results, and 4% (95% CI, 2%-7%) and 0.5% (95% CI, 0.2%-1%) after combined normal MRI and CSF test results. The prognostic value of models determining any type of dementia were in the same order of magnitude although somewhat lower. External validation in Alzheimer's Disease Neuroimaging Initiative 2 showed that our models were highly robust.Conclusions and relevanceThis study provides biomarker-based prognostic models that may help determine AD dementia and any type of dementia in patients with MCI at the individual level. This finding supports clinical decision making and application of biomarkers in daily practice.

Dataset Information

Alterations of Graphic Properties and Related Cognitive Functioning Changes in Mild Alzheimer's Disease Revealed by Individual Morphological Brain Network.

Publications

Alterations of Graphic Properties and Related Cognitive Functioning Changes in Mild Alzheimer's Disease Revealed by Individual Morphological Brain Network.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets